Landolfo S, Herberman R B, Holden H T
J Immunol. 1978 Aug;121(2):695-701.
For MIF production in response to 3 M KCl extracts of tumor, viable and metabolically active macrophages have been shown to be required to interact with the soluble tumor antigens and then come in contact with immune lymphocytes. The Mphi-lymphocyte interaction for MIF production was found to be under the control of genes mapping in the IA subregion of the H-2 complex. However, when intact tumor cells were used as antigen, Mphi were not required for immune lymphocytes to produce MIF. In addition, the interaction of immune lymphocytes with tumor cells for MIF production did not require H-2 compatibility. These and other observations strongly suggest that there are two different mechanisms for MIF production and that these may be mediated by two separate subpopulations of immune lymphocytes.
为了研究巨噬细胞移动抑制因子(MIF)对肿瘤3M氯化钾提取物的反应,已证明有活力且代谢活跃的巨噬细胞需要与可溶性肿瘤抗原相互作用,然后与免疫淋巴细胞接触。发现巨噬细胞与淋巴细胞产生MIF的相互作用受位于H-2复合体IA亚区的基因控制。然而,当完整的肿瘤细胞用作抗原时,免疫淋巴细胞产生MIF不需要巨噬细胞。此外,免疫淋巴细胞与肿瘤细胞产生MIF的相互作用不需要H-2相容性。这些及其他观察结果强烈表明,存在两种不同的MIF产生机制,且可能由免疫淋巴细胞的两个独立亚群介导。